Skip to main content
. Author manuscript; available in PMC: 2012 Apr 27.
Published in final edited form as: JAMA. 2011 Apr 27;305(16):1685–1694. doi: 10.1001/jama.2011.513

Table 4.

Colorectal cancer (stage I-III) mortality by level of post-diagnosis physical activity in strata of nuclear CTNNB1 (β-catenin) status

Nuclear CTNNB1 (−)
Nuclear CTNNB1 (+)
P for
interaction
MET-hours
/week <18
MET-hours
/week ≥18
MET-hours
/week <18
MET-hours
/week ≥18
Colorectal cancer-specific mortality
 No. of events/No. at risk 33/168 6/92 16/140 13/97
 Five-year survival 0.89 0.97 0.93 0.94
 Age-adjusted event incidence rate 0.019 0.006 0.012 0.013
 Univariate HR (95% CI) 1 (referent) 0.31 (0.13-0.73) 1 (referent) 1.14 (0.55-2.37) 0.024
 Stage-matched HR (95% CI) 1 (referent) 0.33 (0.14-0.79) 1 (referent) 1.09 (0.53-2.28) 0.040
 Multivariate stage-matched HR
 (95% CI)
1 (referent) 0.33 (0.13-0.81) 1 (referent) 1.07 (0.50-2.30) 0.046
Overall mortality
 No. of events/No. at risk 67/168 25/92 51/140 33/97
 Five-year survival 0.85 0.90 0.84 0.91
 Age-adjusted event incidence rate 0.040 0.027 0.037 0.032
 Univariate HR (95% CI) 1 (referent) 0.60 (0.38-0.95) 1 (referent) 0.89 (0.57-1.38) 0.22
 Stage-matched HR (95% CI) 1 (referent) 0.61 (0.38-0.97) 1 (referent) 0.85 (0.55-1.33) 0.30
 Multivariate stage-matched HR
 (95% CI)
1 (referent) 0.68 (0.42-1.09) 1 (referent) 0.86 (0.55-1.34) 0.47

The multivariate stage-matched (stratified) Cox regression model included the same set of covariates selected as in Table 2. CI, confidence interval; HR, hazard ratio; MET, metabolic equivalent task.